Anthelmintics

A combination of Sodium Cacodylate, Formalin, and Glutaraldehyde. Ready to use CAS #: 111-30-8, 7758-80-7, 500-00-0, 1310-73-2, 7732-18-5

TSKgel &#174 Amide-80 columns are packed with 3, 5, or 10 micron spherical silica particles that are covalently bonded with carbamoyl groups. The amide stationary phase provides a unique selectivity under regular normal phase conditions or in the

TSKgel &#174 Amide-80 columns are packed with 3, 5, or 10 micron spherical silica particles that are covalently bonded with carbamoyl groups. The amide stationary phase provides a unique selectivity under regular normal phase conditions or in the

TSKgel &#174 Amide-80 columns are packed with 3, 5, or 10 micron spherical silica particles that are covalently bonded with carbamoyl groups. The amide stationary phase provides a unique selectivity under regular normal phase conditions or in the

TSKgel &#174 Amide-80 columns are packed with 3, 5, or 10 micron spherical silica particles that are covalently bonded with carbamoyl groups. The amide stationary phase provides a unique selectivity under regular normal phase conditions or in the

CAS: 7440-33-7 EC No: 231-143-9 MDL No: MFCD00011461 RTECS: YO7175000 Solid Molecular Formula: W MW: 183.84 Melting Point: 3410&deg Boiling Point: 5660&deg Density (g/mL): 19.3

Application Tungsten(IV) sulfide (WS 2 ) is a transition metal dichalcogenide with good catalytic, optical and electronic properties. WS 2 can be used as a solid lubricant for a variety of applications such as aerospace, cutting tools and

Application Tungsten sulfide possesses a pseudo 2 dimensional structure with applications in the Petrochemical industry as a desulfurization catalyst. Tungsten Sulfide nanoparticles have drawn research interest due to their potential in solid-state

Uliledlimab (anti-CD73) is a potent against CD73 humanized monoclonal antibody. Uliledlimab (anti-CD73) inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab (anti-CD73) can be used in research of

Uliledlimab (anti-CD73) is a potent against CD73 humanized monoclonal antibody. Uliledlimab (anti-CD73) inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab (anti-CD73) can be used in research of

Uliledlimab (anti-CD73) is a potent against CD73 humanized monoclonal antibody. Uliledlimab (anti-CD73) inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab (anti-CD73) can be used in research of

Uliledlimab (anti-CD73) is a potent against CD73 humanized monoclonal antibody. Uliledlimab (anti-CD73) inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab (anti-CD73) can be used in research of